Valuation: Treace Medical Concepts, Inc.

Market Cap 329M 298M 275M 249M 469M 30.95B 484M 3.3B 1.31B 16.55B 1.23B 1.21B 52.6B P/E 2026 *
-6.66x
P/E 2027 * -6.92x
Enterprise Value 373M 338M 312M 282M 532M 35.11B 549M 3.74B 1.49B 18.78B 1.4B 1.37B 59.68B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 1.85x
Free-Float
74.57%
Yield 2026 *
-
Yield 2027 * -
1 day+5.53%
1 week+18.67%
Current month+20.54%
1 month+35.19%
3 months+12.66%
6 months+175.26%
Current year+117.96%
1 week 3.42
Extreme 3.42
5.44
1 month 3.42
Extreme 3.42
5.44
Current year 1.17
Extreme 1.17
5.44
1 year 1.17
Extreme 1.17
5.44
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
27.97
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2013
Director of Finance/CFO 56 01/09/2020
Compliance Officer 50 01/10/2022
Director TitleAgeSince
Chairman 54 20/05/2025
Director/Board Member 65 20/11/2020
Director/Board Member 68 20/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
10/24/26 A Tax

Responsable ventes & marketing

-207 0.0003%
9/30/26 A Tax

Compliance Officer

-25,457 0.0391%
8/24/26 A Buy

Chief Executive Officer

11,000 0.0170%
Change 5-day change 1-year change 3-year change Capi.($)
+5.53%+18.67%+58.93%-14.01% 329M
-1.87%-7.15%-15.55%+14.13% 189B
-0.61%-3.78%+5.86%+42.88% 124B
-2.01%-8.03%-14.11%+14.17% 121B
-1.45%-4.87%-42.96%+2.86% 93.09B
-0.14%-1.31%-4.30%+76.84% 66.77B
+0.55%+3.12%+14.12%-8.07% 58.43B
-0.65%-0.08%-2.03%+62.81% 55.35B
+0.96%-1.33%-3.37%+57.35% 49.49B
+1.34%-4.74%-2.30%-7.18% 34.53B
Average +0.17%-0.85%-0.57%+24.18% 79B
Weighted average by Cap. -0.92%-3.10%-9.74%+26.12%

Financials

2026 *2027 *
Net sales 208M 188M 174M 157M 296M 19.55B 305M 2.08B 828M 10.46B 780M 763M 33.23B 221M 200M 184M 167M 314M 20.74B 324M 2.21B 878M 11.1B 828M 810M 35.26B
Net income -52.18M -47.2M -43.59M -39.42M -74.37M -4.91B -76.67M -522M -208M -2.62B -196M -192M -8.34B -50.96M -46.1M -42.58M -38.5M -72.64M -4.79B -74.88M -510M -203M -2.56B -191M -187M -8.15B
Net Debt 44.31M 40.08M 37.02M 33.48M 63.16M 4.17B 65.11M 444M 176M 2.23B 166M 163M 7.08B 78.72M 71.21M 65.77M 59.47M 112M 7.4B 116M 788M 313M 3.96B 295M 289M 12.58B
Projected Income Statement - Annual - Treace Medical Concepts, Inc.
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
12/11/26 $5.340 +5.53% 310,091
11/11/26 $5.060 +3.69% 579,331
10/11/26 $4.880 +2.09% 580,753
09/11/26 $4.780 +18.61% 1,094,543
06/11/26 $4.030 -3.59% 596,716
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Treace Medical Concepts, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
5.060USD
Average target price
6.167USD
Spread / Average Target
+21.87%
  1. Stock Market
  2. Stocks
  3. TMCI Stock